Covered recipient · General Payments record
NICOLE ZUMPF
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2022–2024
$2,127.83
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.26 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.57 | 10 |
| ABIOMED | $106.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.67 | 1 |
| REVANCE THERAPEUTICS, INC. | $51.33 | 3 |
| Galderma Laboratories, L.P. | $49.17 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464580 | CMS |
| ABBVIE INC. | $7.70 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464582 | CMS |
| ABBVIE INC. | $2.61 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464584 | CMS |
| ABBVIE INC. | $6.79 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464586 | CMS |
| ABBVIE INC. | $11.96 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464588 | CMS |
| ABBVIE INC. | $21.91 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464590 | CMS |
| ABBVIE INC. | $150.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464592 | CMS |
| ABBVIE INC. | $10.24 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464594 | CMS |
| ABBVIE INC. | $13.15 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464596 | CMS |
| ABBVIE INC. | $26.43 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108464598 | CMS |
| ABIOMED | $106.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142209350 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.67 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117995248 | CMS |
| Galderma Laboratories, L.P. | $21.86 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145403111 | CMS |
| Galderma Laboratories, L.P. | $13.31 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145403113 | CMS |
| Galderma Laboratories, L.P. | $14.00 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145403115 | CMS |
| REVANCE THERAPEUTICS, INC. | $13.93 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147954530 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.87 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147954532 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.53 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147954534 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.